0
0

Providing for consideration of the bill (H.R. 5515) to authorize appropriations for fiscal year 2019 for military activities of the Department of Defense and for military construction, to prescribe military personnel strengths for such fiscal year, and for other purposes; providing for consideration of the bill (S. 204) to authorize the use of unapproved medical products by patients diagnosed with a terminal illness in accordance with State law, and for other purposes; and providing for consideration of the bill (S. 2155) to promote economic growth, provide tailored regulatory relief, and enhance consumer protections, and for other purposes.

4/7/2025, 3:21 PM

Summary of Bill HRES 905

Bill 115 HRES 905 is a resolution that sets the rules for considering three important bills in the US Congress. The first bill, H.R. 5515, authorizes funding for military activities of the Department of Defense and military construction for the fiscal year 2019. It also sets the number of military personnel for that year. The second bill, S. 204, allows patients diagnosed with a terminal illness to use unapproved medical products as long as it is in accordance with State law. The third bill, S. 2155, aims to promote economic growth, provide regulatory relief, and enhance consumer protections. The resolution ensures that these bills are debated and voted on in a fair and organized manner in Congress.

Current Status of Bill HRES 905

Bill HRES 905 is currently in the status of Bill Introduced since May 21, 2018. Bill HRES 905 was introduced during Congress 115 and was introduced to the House on May 21, 2018.  Bill HRES 905's most recent activity was Motion to reconsider laid on the table Agreed to without objection. as of May 22, 2018

Bipartisan Support of Bill HRES 905

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
0
Democrat Cosponsors
0
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HRES 905

Primary Policy Focus

Congress

Comments